Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Indivior Pharmaceuticals (INDV) FCF Margin (2024 - 2025)

Indivior Pharmaceuticals (INDV) has 2 years of FCF Margin data on record, last reported at 6.37% in Q3 2025.

  • For Q3 2025, FCF Margin fell 409.0% year-over-year to 6.37%; the TTM value through Dec 2025 reached 3.39%, up 82.0%, while the annual FY2024 figure was 3.03%, 3121.0% up from the prior year.
  • FCF Margin reached 6.37% in Q3 2025 per INDV's latest filing, down from 5.63% in the prior quarter.
  • Across five years, FCF Margin topped out at 1.34% in Q2 2024 and bottomed at 13.73% in Q1 2024.